Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


Vaccine Recommendations and Guidelines of the ACIP








Meningococcal ACIP Vaccine RecommendationsAdvisory Committee on Immunization Practices (ACIP)						Print
																Related Pages
										On This Page
			Current RecommendationsArchived
		Published in Morbidity and Mortality Weekly Report (*MMWR*)The Advisory Committee on Immunization Practices (ACIP) provides advice and guidance to the Director of the CDC regarding use of vaccines and related agents for control of vaccine-preventable diseases in the civilian population of the United States. Recommendations made by the ACIP are reviewed by the CDC Director and, if adopted, are published as official CDC/HHS recommendations in the Morbidity and Mortality Weekly Report (MMWR).CURRENT Meningococcal Vaccine Recommendations
*MMWR*, September 25, 2020, Vol 69(9);1–41Meningococcal Vaccination: Recommendations of the Advisory Committee on Immunization Practices, United States, 2020Print version [44 pages]
See also:
ACIP-VFC ResolutionARCHIVED Historical Meningococcal Immunization Publications
For your convenience, these archived publications can be used for historical and research purposes.
*MMWR*, May 19, 2017, Vol 66(19);509–513Updated Recommendations for Use of MenB-FHbp Serogroup B Meningococcal Vaccine — Advisory Committee on Immunization Practices, 2016Print version [5 pages]
*MMWR*, November 4, 2016, Vol 65(43);1189–1194Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons — Advisory Committee on Immunization Practices, 2016Print version [6 pages]
*MMWR*, October 23, 2015, Vol 64(41);1171-6Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015Print version [24 pages]
*MMWR*, June 12, 2015, Vol 64(22);608-612Use of Serogroup B Meningococcal (MenB) Vaccines in Persons Aged ≥10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015Print version [24 pages]
*MMWR*, June 20, 2014, Vol 63(24);527-530Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk, 2013Print version [16 pages]
*MMWR*, March 22, 2013, Vol 62(RR-02);1-22Prevention and Control of Meningococcal DiseasePrint version [32 pages]
*MMWR*, January 25, 2013, Vol 62(03);52-54Infant Meningococcal Vaccination: ACIP Recommendations and RationalePrint version [20 pages]
*MMWR*, October 14, 2011, Vol 60(40);1391-1392Recommendation of the ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal DiseasePrint version [2.03MB, 36 pages]
*MMWR*, August 5, 2011, Vol 60(30);1018-1019Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — ACIP, 2011Print version [1.12MB, 36 pages]
*MMWR*, January 28, 2011, Vol 60(03);72-76Updated Recommendations for Use of Meningococcal Conjugate Vaccines — ACIP, 2010Print version [28 pages]
*MMWR*, March 12, 2010, Vol 59(09);273Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use — ACIP, 2010Print version [36 pages]
*MMWR*, September 25, 2009, Vol 58(37);1042-1043Updated Recommendation from the ACIP for Revaccination of Persons at Prolonged Increased Risk for Meningococcal DiseasePrint version [1.49MB, 32 pages]
*MMWR*, May 2, 2008, Vol 57(17);462-465Report from ACIP: Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
(PDF not available)
*MMWR*, December 7, 2007, Vol 56(48);1265-1266*Notice to Readers*: Recommendation from ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal DiseasePrint version [24 pages]
*MMWR*, August 10, 2007, Vol 56(31);794-795*Notice to Readers*: Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate VaccinePrint version [28 pages]
*MMWR*, November 3, 2006, Vol 55(43);1177*Notice to Readers*: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11-12 YearsPrint version [23 pages]
*MMWR*, September 22, 2006, Vol 55(37);1016-1017Inadvertent Misadministration of Meningococcal Conjugate Vaccine — United States, June-August 2005Print version [24 pages]
*MMWR*, May 26, 2006, Vol 55(20);567-568*Notice to Readers*: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11-12 YearsPrint version [32 pages]
*MMWR*, May 27, 2005, Vol 54(RR-07);1-21Prevention and Control of Meningococcal DiseasePrint version [28 pages]
*MMWR*, Feb 14, 1997, Vol 46(RR-5);13-21Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the ACIPPrint version [27 pages]Top of Page
							
					
							Last Reviewed:  December 12, 2023						Source: 	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeACIP Recs Home
Vaccine-Specific Recommendationsplus icon
Anthrax
Cholera
COVID-19
Dengue
DTaP/IPV/Hib/HepB
DTaP/Tdap/Td
Ebola
Hepatitis A
Hepatitis B
Hib
HPV
Influenza
Japanese Encephalitis
MMR
MMRV
Meningococcal
Pneumococcal
Polio
Rabies
Rotavirus
RSV
Smallpox
TBE
Typhoid
Varicella
Yellow Fever
Zoster (Shingles)
Recs Listed by Date
Comprehensive Recommendations and Guidelinesplus icon
General Best Practice Guidelinesplus icon
Introduction
History
Timing and Spacing of Immunobiologics
Contraindications and Precautions
Preventing and Managing Adverse Reactions
Vaccine Administration
Storage and Handling of Immunobiologics
Altered Immunocompetence
Special Situations
Vaccinations Records
Vaccination Programs
Vaccine Information Sources
Appendix 1: Glossary
Appendix 2: Membership
Archived ACIP Recs
Vaccine Recommendations for Emergency Situations To receive email updates about this page, enter your email address: Email Address			What's this?				Submit
 Vaccines & ImmunizationsVFC ResolutionsACIP Web SiteCDC's International Travelers Yellow BookClinical Travel Notices, Updates, and Vaccine Shortages


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue